Cargando…

IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis

OBJECTIVES: A previously identified signal transduction and activator of transcription-3 (STAT3) target-enriched gene signature in circulating CD4+ T cells of patients with early rheumatoid arthritis (RA) was prominent in autoantibody-negative individuals. Here, interleukin (IL)-6-mediated STAT sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Amy E, Pratt, Arthur G, Sedhom, Mamdouh A K, Doran, John Paul, Routledge, Christine, Hargreaves, Ben, Brown, Philip M, Lê Cao, Kim-Anh, Isaacs, John D, Thomas, Ranjeny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Basic and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752669/ https://www.ncbi.nlm.nih.gov/pubmed/25649145 http://dx.doi.org/10.1136/annrheumdis-2014-205850

Ejemplares similares

Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 ‘shared epitope’ alleles
por: Wagner, Catriona A, et al.
Publicado: (2015)

A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease
por: Pratt, Arthur G, et al.
Publicado: (2012)

Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis
por: Harry, Rachel A, et al.
Publicado: (2010)

Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies
por: Song, Y.W., et al.
Publicado: (2010)

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
por: Boyle, D L, et al.
Publicado: (2015)

Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway
por: González-Alvaro, I, et al.
Publicado: (2008)

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
por: Bell, G M, et al.
Publicado: (2017)

Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis
por: Reynolds, G, et al.
Publicado: (2016)

The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort
por: Smith, Samantha Louise, et al.
Publicado: (2017)

The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE
por: Hagberg, Niklas, et al.
Publicado: (2018)

Dendritic cell integrin expression patterns regulate inflammation in the rheumatoid arthritis joint
por: Schittenhelm, Leonie, et al.
Publicado: (2020)

Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay
por: Grabiec, Aleksander M, et al.
Publicado: (2011)

Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems
por: Valesini, Guido, et al.
Publicado: (2009)

MICL controls inflammation in rheumatoid arthritis
por: Redelinghuys, Pierre, et al.
Publicado: (2016)

Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis
por: Filková, Mária, et al.
Publicado: (2014)

STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
por: Zhang, Liang, et al.
Publicado: (2022)

Prediction of treatment response by anticitrullinated protein antibodies (ACPA) levels among patients with rheumatoid arthritis
por: Hernández, Raquel, et al.
Publicado: (2012)

Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis
por: Chen, Yi-Ming, et al.
Publicado: (2017)

Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy
por: Ide, Veerle, et al.
Publicado: (2018)

Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis
por: Cioffi, Giovanni, et al.
Publicado: (2020)

Anticitrullinated antibodies recognize rheumatoid arthritis associated T-cell epitopes modified by bacterial L-asparaginase
por: Batsalova, Tsvetelina, et al.
Publicado: (2023)

Constitutive activation of the EGFR–STAT1 axis increases proliferation of meningioma tumor cells
por: Ferluga, Sara, et al.
Publicado: (2020)

Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab
por: Herenius, M M J, et al.
Publicado: (2011)

Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
por: Rossmeisl, John H, et al.
Publicado: (2020)

Identification of a transitional fibroblast function in very early rheumatoid arthritis
por: Filer, Andrew, et al.
Publicado: (2017)

Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors
por: Gao, W, et al.
Publicado: (2016)

Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency
por: Carapito, Raphael, et al.
Publicado: (2018)

Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma
por: Brahm, Cyrillo G, et al.
Publicado: (2020)

Receptor-driven invasion profiles in diffuse intrinsic pontine glioma
por: Karki, Anju, et al.
Publicado: (2021)

Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide
por: Wythe, Sarah E, et al.
Publicado: (2013)

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis
por: Greven, D E A, et al.
Publicado: (2015)

Chemotaxis of Vδ2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis
por: Mo, Wen-Xiu, et al.
Publicado: (2017)

Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis
por: Genovese, Mark C, et al.
Publicado: (2018)

Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis
por: Montgomery, Anna B, et al.
Publicado: (2016)

Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis
por: Leonard, Dag, et al.
Publicado: (2018)

Single-cell sequencing of immune cells from anticitrullinated peptide antibody positive and negative rheumatoid arthritis
por: Wu, Xunyao, et al.
Publicado: (2021)

The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation
por: Tang, Man Wai, et al.
Publicado: (2016)

An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation
por: Roberts, Amity R, et al.
Publicado: (2016)

Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis
por: Yeo, Lorraine, et al.
Publicado: (2011)

Identification of the NF-κB activating protein-like locus as a risk locus for rheumatoid arthritis
por: Xie, Gang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_24afl48p4v4kpk62ouo0ll4v0k